Clinical trial
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial for the Safety and Efficacy of Pirfenidone in the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
NCT01504334 is registered in ClinicalTrials.gov with Beijing Kawin Technology Share-Holding Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Double-blind, Placebo-controlled Trial for the Safety and Efficacy of Pirfenidone in the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
- Lead sponsor
- Beijing Kawin Technology Share-Holding Co., Ltd.
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- January 31, 2012
- Completion date
- March 31, 2013
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.